Pieris Pharmaceuticals Inc

NASDAQ:PIRS  
16.67
-0.36 (-2.11%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Pieris Pharmaceuticals Inc Stock, NASDAQ:PIRS

225 Franklin Street, 9th floor, Boston, Massachusetts 02109
United States of America
Phone: +1.857.246.8998
Number of Employees: 50

Description

Pieris Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in the discovery and development of Anticalin-based drugs. Its pipeline includes immuno-oncology, respiratory, and anemia and other disease areas. The company was founded by Claus Schalper and Arne Skerra in 2001 and is headquartered in Boston, MA.